DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Endroit courant :
>
> This Story


Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment

 

Business Affairs Homepage

Olympus expands its EndoTherapy product line One new device and two business deals

UK has third lowest number of radiologists per population out of 31 EU countries Nearly two-thirds of posts remained unfilled for 12 months or longer in 2016

Survey finds medical devices not meeting provider expectations A call for higher-quality clinical evidence, flexible contract options and better customer service

European Society of Radiology calls for diagnostics to be better represented in value-based care Diagnosis 'is the basis for any treatment decision'

GE Healthcare receives Carequality certification Centricity customers can share data among multiple providers

Canon elaborates on financial goals with Toshiba Medical in the fold 'Launching into the global health market ... in one fell swoop'

Former Cleveland Clinic Innovations director pleads guilty to fraud Scheme cost the institution over $2.7 million

NuVasive files lawsuit against former vice chairman Alleges breach of fiduciary duties and violation of contractual obligations

Blue Earth Diagnostics inks Axumin deal with Seibersdorf Laboratories Manufacturing and distribution in certain European countries

Philips to halt production of external defibrillators in two U.S. facilities OEM looks ahead, calling consent decree 'consequence of past sins'

Boston Scientific has agreed to acquire
Apama Medical for $300 million

Boston Scientific to acquire Apama Medical

par John Fischer , Staff Reporter
Boston Scientific Corporation has agreed to acquire Apama Medical Inc. for a sum of $300 million.

The acquisition of the privately-held, California-based company will allow Boston Scientific to expand its electrophysiology portfolio, combining its radiofrequency point-by-point solution with Apama’s single-shot balloon ablation technology for the treatment of atrial fibrillation (AF).

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory DOTmed Certified



“Single-shot pulmonary vein isolation (PVI) ablation is a high growth market segment,” Joe Fitzgerald, president of rhythm management at Boston Scientific, told HCB News. “Our current electrophysiology (EP) portfolio includes a radiofrequency (RF) point-by-point solution, and the Apama technology, upon regulatory approval, will allow us to expand into the single-shot market segment, and ultimately bolster our entire EP portfolio.”

PVI is the current standard form of treatment in AF ablations and is performed using either point-by-point RF-based ablation or single-shot balloon-based ablation.

As part of the agreement, Boston Scientific will acquire Apama’s concept device, the Apama Radiofrequency (RF) Balloon Catheter System, which combines the primary benefits of RF point-by-point and balloon-based ablation approaches, allowing physicians to administer different amounts of energy and shorten procedure times.

Boston Scientific plans to integrate the RF balloon system with its RHYTHMIA HDx Mapping System, the only high density and high resolution map in the industry, to provide physicians with never before seen visualization of the heart during ablation procedures. It also will acquire intellectual property and 40 employees from Apama.

“The Apama RF Balloon System offers benefits to both patients and physicians as its initial clinical results have demonstrated that the technology meets the study endpoints of safety and efficacy, while also offering improvements to procedure efficiency,” Amr Salahieh, the CEO and president of Apama Medical, told HCB News.

The RHYTHMIA HDx Mapping System is available to consumers. The Apama RF Balloon Catheter System is still being studied and is not yet for sale.

An upfront cash transaction of $175 million has already been paid. A maximum of $125 million in contingent payments will be made between 2018 and 2020 based on successes in clinical and regulatory processes.

Completion of the acquisition is expected in the fourth quarter of 2017, subject to customary closing conditions.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Publicité
Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Annuaire
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Les travaux/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Certification Récentes
Voir les utilisateurs récemment certifiés
Evaluation Récentes
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service le forum de techniciens
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2017 DOTmed.com, Inc.
TOUS DROITS RÉSERVÉS